Bullish
Cue Biopharma Inc. (CUE) has announced a private placement financing expected to generate $30 million in gross proceeds from accredited investors. Thi...
Neutral
This article provides an overview of CUE BIOPHARMA O.N.'s financial statements, listed on the Munich Stock Exchange under the ticker 1UC0. It details ...
Neutral
Wall Street Zen has upgraded Cue Biopharma (NASDAQ:CUE) to a "strong-buy" rating, despite Weiss Ratings reaffirming a "sell" rating and the overall co...